Mobidiag

Molecular diagnostic company focusing on detection of infectious diseases

Mobidiag is a biotechnology company specializing in developing and marketing innovative solutions for molecular diagnostics of infectious diseases. Since its inception in 2000, Mobidiag has been serving the European clinical diagnostics market with offices in Finland (headquarters), France, UK and Sweden, and worldwide distributors. Mobidiag addresses both high to medium volume screening with its main product line Amplidiag and upcoming Novodiag (CE-mark pending). - Amplidiag is a family of diagnostic tests relying on multiplex real-time PCR for high-volume screening of gastrointestinal pathogens and antibiotic resistance (e.g. bacteria, virus, parasite, superbug) directly from stool samples. Amplidiag Easy takes the suite – unmatched in performance and capability – even further by automating the workflow from primary sample to final results. - Novodiag is a turnkey, easy-to-use solution, providing rapid and sensitive on-demand results. The fully automated platform is ideal for complementing high throughput screening solutions enabling immediate detection of infectious diseases when time-to-result is critical.